• About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW
Click Here To Share Your Rare Disease Story
Click Here To Share Your Story With High-Risk Cutaneous Squamous Cell Carcinoma (cSCC)
Click Here To Share Your Story With MASH

1514 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 17
Editor’s Choice: Balance Awareness Week and Study Updates

Editor’s Choice: Balance Awareness Week and Study Updates

Happy Friday! Sept. 13-19 is Balance Awareness Week. It's intended to bring attention to balance-related vestibular disorders such as Meniere’s disease and vestibular migraine. Looking for ways to help out?…

Continue Reading Editor’s Choice: Balance Awareness Week and Study Updates
A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome

A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome

According to an article from GlobeNewswire, new clinical evidence supports the use of gelpaglutide as a once-weekly treatment for short bowel syndrome. Zealand Pharma completed a Phase I clinical trial…

Continue Reading A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome
Caplyta Shows Strong Remission Gains in Phase III Depression Study

Caplyta Shows Strong Remission Gains in Phase III Depression Study

As reported by the European Pharmacy Review, a combination approach using Johnson & Johnson’s small‑molecule therapy Caplyta (lumateperone) alongside standard antidepressants continues to show promising results for adults with major…

Continue Reading Caplyta Shows Strong Remission Gains in Phase III Depression Study
New Study Finds Keytruda Combo Falls Short of Expectations in Unresectable-Non-Metastatic Hepatocellular Carcinoma

New Study Finds Keytruda Combo Falls Short of Expectations in Unresectable-Non-Metastatic Hepatocellular Carcinoma

There may be several reasons that HCC cancer of the liver cannot be removed. It may be due to the size of the tumor, or location proximity to major blood…

Continue Reading New Study Finds Keytruda Combo Falls Short of Expectations in Unresectable-Non-Metastatic Hepatocellular Carcinoma
Yes, I CAN: Learn About a Clinical Research Study for IgA Nephropathy (IgAN)

Yes, I CAN: Learn About a Clinical Research Study for IgA Nephropathy (IgAN)

Acknowledgment: This story is sponsored by Alexion Pharmaceuticals and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant, vetted,…

Continue Reading Yes, I CAN: Learn About a Clinical Research Study for IgA Nephropathy (IgAN)
Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim

Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim

Clinical-stage biopharmaceutical company Savara Inc. was founded on a desire to develop innovative therapies for people living with rare respiratory diseases. The company's work over the past few years centers…

Continue Reading Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim
Study: Specialized Immune Responses Keep Some People from Contracting COVID-19

Study: Specialized Immune Responses Keep Some People from Contracting COVID-19

The COVID-19 pandemic took our world by storm. COVID-19 affected hundreds of millions of people globally and was associated with tens of millions of deaths. Today, people are still dying…

Continue Reading Study: Specialized Immune Responses Keep Some People from Contracting COVID-19
Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®

Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®

This week Neurocrine Biosciences announced the results of its KINECT®-4 Phase 3 study of INGREZZA® capsules. Results of the trial were published in the Journal of Clinical Psychopharmacology. A long-term…

Continue Reading Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®
  • Go to the previous page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 190
  • Go to the next page
You Are Not Alone: Empowering the Advanced Kidney Cancer Community
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
Read Full Story Here
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info